Recombinant SARS-CoV-2 Spike 抗体 (RBD)
Quick Overview for Recombinant SARS-CoV-2 Spike 抗体 (RBD) (ABIN7271727)
抗原
See all SARS-CoV-2 Spike 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- RBD
-
原理
- Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)
-
特异性
- This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain.
-
产品特性
- Recombinant Antibodies produced in HEK293. Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.
-
免疫原
- Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.
-
亚型
- IgA
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Powder
-
储存条件
- -20 °C
-
储存方法
- -20°C
-
-
- SARS-CoV-2 Spike
-
背景
- It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
抗原
-